MDM2‐DAXX‐HAUSP complex is a prominent target of several anticancer drugs, and its degradation in cancer cells leads to p53 activation, cell cycle arrest, and programmed cell death.4, 13, 14, 15, 16. This evidence concerns the gene TP53 and cancer.